| | |
Patients (n)
|
Percentage
|
|---|
|
Sex
|
Men
|
43
|
48.9%
|
|
Women
|
45
|
51.1%
|
|
Age (years)
|
Mean (min-max)
|
70.9
|
(25–93)
|
|
RIN
|
Mean (min-max)
|
8.9
|
(7.5-10)
|
|
Duke's Stage
|
A
|
24
|
27.27%
|
|
B
|
26
|
29.55%
|
|
C
|
19
|
21.59%
|
|
D
|
19
|
21.59%
|
|
MSS/MSI
|
MSS
|
79
|
89.8%
|
|
MSI
|
9
|
10.2%
|
|
Location
|
Ascending C.
|
33
|
37.5%
|
|
Sigmoid
|
32
|
36.4%
|
|
Rectum
|
14
|
15.9%
|
|
Descending C.
|
3
|
3.4%
|
| |
Transverse C.
|
6
|
6.8%
|
|
Mut. PI3K
|
Exon 9
|
12
|
13.6%
|
|
Exon 20
|
8
|
9.1%
|
|
Wild Type
|
68
|
77.3%
|
|
Mut. B-Raf
|
Mutated
|
8
|
9.1%
|
|
Wild Type
|
80
|
90.9%
|
|
Mut. K-ras
|
Codon 12
|
28
|
31.8%
|
|
Codon 13
|
6
|
6.8%
|
|
Wild Type
|
54
|
61.4%
|
|
Histologic grade
|
Undifferentiated
|
1
|
1.1%
|
| |
Poorly diff.
|
5
|
5.7%
|
| |
Moderately diff.
|
51
|
58.0%
|
| |
Well diff.
|
31
|
35.2%
|
|
Histologic subtypes
|
Conventional
|
78
|
88.64%
|
| |
Mucinous
|
10
|
11.36%
|
|
Tumoral margin
|
Expansive
|
16
|
18.18%
|
| |
Infiltrative
|
61
|
69.32%
|
| |
Mixed
|
11
|
12.50%
|
|
Vascular invasion
|
Yes
|
33
|
37.50%
|
| |
No
|
55
|
62.50%
|
|
Perineural invasion
|
Yes
|
8
|
9.09%
|
| |
No
|
80
|
90.91%
|
|
Lymphocyte infiltration
|
Absent
|
53
|
60.23%
|
| |
Low
|
15
|
17.05%
|
|
Medium
|
17
|
19.32%
|
| |
High
|
3
|
3.41%
|
-
RIN: RNA integrity factor.
